CY1995A - Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid - Google Patents

Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid

Info

Publication number
CY1995A
CY1995A CY199597A CY199597A CY1995A CY 1995 A CY1995 A CY 1995A CY 199597 A CY199597 A CY 199597A CY 199597 A CY199597 A CY 199597A CY 1995 A CY1995 A CY 1995A
Authority
CY
Cyprus
Prior art keywords
clavulanic acid
amino
pharmaceutically acceptable
acceptable salts
producing pharmaceutically
Prior art date
Application number
CY199597A
Other languages
English (en)
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of CY1995A publication Critical patent/CY1995A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
CY199597A 1992-03-10 1997-09-05 Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid CY1995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0047292A AT400033B (de) 1992-03-10 1992-03-10 Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben

Publications (1)

Publication Number Publication Date
CY1995A true CY1995A (en) 1997-09-05

Family

ID=3491521

Family Applications (1)

Application Number Title Priority Date Filing Date
CY199597A CY1995A (en) 1992-03-10 1997-09-05 Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid

Country Status (21)

Country Link
US (4) US20010036940A1 (fr)
JP (2) JP2817563B2 (fr)
CN (3) CN1045604C (fr)
AT (1) AT400033B (fr)
AU (1) AU659282B2 (fr)
CH (1) CH685054A5 (fr)
CY (1) CY1995A (fr)
DE (1) DE4307422B4 (fr)
DK (1) DK26093A (fr)
ES (1) ES2058029B1 (fr)
FI (1) FI101965B (fr)
FR (1) FR2688506B1 (fr)
GB (1) GB2264944B (fr)
GR (1) GR1002329B (fr)
HK (1) HK42696A (fr)
IE (1) IE70926B1 (fr)
IT (1) IT1261213B (fr)
NL (1) NL9300430A (fr)
NO (1) NO301372B1 (fr)
SE (1) SE508043C2 (fr)
TW (1) TW364907B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
ATE198892T1 (de) 1993-11-17 2001-02-15 Biochemie Gmbh Trennung von cephalosporinisomeren
GB9426261D0 (en) * 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
TR199700828T1 (xx) * 1995-02-25 1998-04-21 Spurcourt Limited .Klavulanik asit tuzlar�.
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
AU5411099A (en) * 1998-07-16 2000-02-07 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
CN1209099C (zh) * 1999-04-01 2005-07-06 Dsm公司 结晶化附聚物
ATE273982T1 (de) * 2000-05-13 2004-09-15 Smithkline Beecham Plc Verfahren zur reinigung eines salzes der clavulansäure
US9180149B2 (en) * 2005-09-07 2015-11-10 Sillajen Biotherapeutics, Inc. Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
JP7028064B2 (ja) 2018-05-30 2022-03-02 横河電機株式会社 機器保全装置、機器保全方法、機器保全プログラム及び記録媒体
CN115768544A (zh) 2020-07-10 2023-03-07 碳清洁解决方案有限公司 用低品位热从溶剂去除二氧化碳的方法和系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288800A (en) 1962-05-29 1966-11-29 Squibb & Sons Inc Schiff's bases of 6-amino-penicillanic acid and purification of 6-aminopenicillanic acid by the use thereof
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
IE41109B1 (en) 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
US4110165A (en) 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
GB1543563A (en) 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
US4144242A (en) 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB1561395A (en) 1976-02-26 1980-02-20 Beecham Group Ltd -lactam antibiotic
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB2003863B (en) 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
DE2861607D1 (en) 1977-11-26 1982-03-11 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
MX7417E (es) 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
GB8618888D0 (en) 1986-08-01 1986-09-10 Davy Mckee Ltd Process
US5679789A (en) 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
ES2074048T3 (es) 1987-01-29 1995-09-01 Beecham Group Plc Procedimiento para la cristalizacion de clavulanato de potasio.
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT399155B (de) 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB2298201B (en) 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
TR199700828T1 (xx) 1995-02-25 1998-04-21 Spurcourt Limited .Klavulanik asit tuzlar�.
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
US6414142B1 (en) 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
AU5551698A (en) 1996-11-11 1998-06-03 Gist-Brocades B.V. Process for the preparation of salts and esters of clavulanic acid

Also Published As

Publication number Publication date
AU3407093A (en) 1993-09-16
ES2058029B1 (es) 1995-05-01
JPH1067785A (ja) 1998-03-10
FI101965B1 (fi) 1998-09-30
USH2158H1 (en) 2006-06-06
IT1261213B (it) 1996-05-09
CN1150153A (zh) 1997-05-21
GB2264944A (en) 1993-09-15
IE930172A1 (en) 1993-09-22
NO930829L (no) 1993-09-13
GR1002329B (el) 1996-05-15
DE4307422B4 (de) 2004-11-25
FR2688506B1 (fr) 1995-06-23
JP2817563B2 (ja) 1998-10-30
DK26093A (da) 1993-09-11
ES2058029A1 (es) 1994-10-16
FI931032A (fi) 1993-09-11
DE4307422A1 (de) 1993-09-30
DK26093D0 (da) 1993-03-09
NO930829D0 (no) 1993-03-08
CN1045604C (zh) 1999-10-13
SE9300758D0 (sv) 1993-03-08
ITRM930147A0 (it) 1993-03-10
CH685054A5 (de) 1995-03-15
HK42696A (en) 1996-03-22
CN1079743A (zh) 1993-12-22
SE508043C2 (sv) 1998-08-17
GB9304704D0 (en) 1993-04-28
SE9300758L (sv) 1993-09-11
ATA47292A (de) 1995-01-15
CN1145906A (zh) 1997-03-26
FI931032A0 (fi) 1993-03-09
JPH0641143A (ja) 1994-02-15
AT400033B (de) 1995-09-25
US20010036940A1 (en) 2001-11-01
FR2688506A1 (fr) 1993-09-17
ITRM930147A1 (it) 1994-09-10
US20030203886A1 (en) 2003-10-30
US20030022882A1 (en) 2003-01-30
NO301372B1 (no) 1997-10-20
GB2264944B (en) 1995-09-06
AU659282B2 (en) 1995-05-11
US20020072513A1 (en) 2002-06-13
IE70926B1 (en) 1997-01-15
GR930100090A (el) 1993-11-30
TW364907B (en) 1999-07-21
NL9300430A (nl) 1993-10-01
FI101965B (fi) 1998-09-30

Similar Documents

Publication Publication Date Title
HU9501214D0 (en) New process for producing clavulanic acid, and pharmaceutically acceptable salts and esters thereof and/or their purification
GB2264944B (en) Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid
IL113433A (en) Tablet formulations comprising amoxycillin and salts of clavulanic acid
DE3263917D1 (en) Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof
HUT74885A (en) New process for the preparation of a salt of clavulanic acid
HUP9901055A3 (en) Preparation of clavulanate salts
ZA969734B (en) Process for producing clavulanic acid and/or its salts
CS332291A3 (en) Thienylacetic acid amide derivatives and their pharmaceutically acceptable addition salts and process for preparing thereof
HK1006571A1 (en) Clavulanic acid salts
IL116498A0 (en) Clavulanic acid salts
HU9300141D0 (en) Method for producing aryl-acetic acid derivatives and their alkaline salts
HUT39465A (en) Process for producing new alkyl-amino-furanone derivatives and pharmaceutically acceptable salts
AR245135A1 (es) Novedosas aminas organofosforadas,particularmente sales de 1,4,2-oxazafosfolidin-4-acetico,2-alcoxi-2-oxidos y el uso de tales compuestos como herbicidas y regulador del crecimiento vegetal.
GB2298201B (en) Clavulanic acid salts
SI0647229T1 (en) Diamine salts of clavulanic acid
HUP9601278A2 (en) Process for the preparation of 2-fluorcyclopropylamine sulphonic acid salts and 2-fluorcyclopropylisocyanates
HU205110B (en) Process for producing new, opticallly active octahydroindolo /2,3-a/quinolizine tetraesters and their acid addition salts
HU205109B (en) Process for producing new, optically active octahydroindolo /2,3-a/ quinolizine-half acid-half ester derivatives and hexahydroindolo/2,3-a/quinolizinium salts
CS380988A1 (en) Method of l-lysine's hydrochloride's dihydrate regeneration
HUT43621A (en) Process for producing alkylamino-furanone derivatives and pharmaceutically acceptable salts
CS409588A1 (en) Method of hydrophilic polymers' strongly acid derivatives preparation
GB9226874D0 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
GB9423862D0 (en) Method od preparing clavulanic acid salts
HU9201501D0 (en) Processs for the production of n-substituted-n-demethyl 2-fluor-apocodein and apomorphinic derivatives and their salts
CS602388A1 (en) Method of n-salicyliden-d,l-copper glutamate's trihydrate preparation